Combination Products Raise Manufacturing Challenges

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2005, Volume 29, Issue 3

New fixed-dose combination drugs aim to enhance safety and efficacy, while regulators clear a path for more drug–device combination products.

Related Content:

FormulationSolid/Semi-Solid DosageManufacturingQuality SystemsRegulatory WatchDosage FormsManufacturing, Solid Dosage DrugsPharmaceutical Technology-03-02-2005
FUJIFILM Diosynth Biotechnologies Completes New Viral Vector Gene Therapy Manufacturing Facility in UK
The European Commission Approves Severe Alopecia Areata Treatment
Continuous Manufacturing is Here to Stay (PDA/FDA Joint Regulatory Conference 2023)